Meningococcal meningitis: Vaccination outbreak response and epidemiological changes in the African meningitis belt

International Health

Volumn 7, Issue 4, 2015, Pages 226-227

  Artal, Francisco Javier Carod ^a,b  

^a RAIGMORE HOSPITAL   (United Kingdom)

^b UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

Author keywords

Conjugate vaccine; Meningitis surveillance; Neisseria meningitides; Polysaccharide vaccine; Serogroup A; Vaccination outbreak response

Indexed keywords

MENINGOCOCCUS VACCINE; VACCINE;

BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BURKINA FASO; CHAD; EARLY INTERVENTION; EPIDEMIC; EPIDEMIC MENINGITIS; GHANA; GUINEA; HUMAN; IMMUNOLOGICAL MEMORY; INCIDENCE; INFECTION CONTROL; KENYA; MORBIDITY; MORTALITY; NIGER; NIGERIA; NOTE; PHARYNX; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PROTECTION; SEASONAL VARIATION; SUDAN; VACCINATION; AFRICA; DISEASE OUTBREAKS; EPIDEMICS; MENINGITIS, MENINGOCOCCAL;

AFRICA; DISEASE OUTBREAKS; EPIDEMICS; HUMANS; INCIDENCE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; VACCINATION; VACCINES, CONJUGATE;

EID: 84941963323     PISSN: 18763413     EISSN: 18763405     Source Type: Journal    
DOI: 10.1093/inthealth/ihv025     Document Type: Note

References (10)

1. Al-Tawfiq JA, Clark TA, Memish ZA. Meningococcal disease: the organism, clinical presentation, and worldwide epidemiology. J Travel Med 2010;17(Supp):3-8.
2. Woods CW, Armstrong G, Sackey SO et al. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa. Lancet 2000;355:30-3.
3. Funk A, Uadiale K, Kamau C et al. Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in northern Nigeria, 2013-14. PLoS Curr 2014;6:pii:ecurrents.outbreaks.b50c2aaf 1032b3ccade0fca0b63ee518.
4. Savadogo M, Kyélem N, Yélbéogo D et al. The Neisseria meningitidis W135 epidemic in 2012 in Burkina Faso [in French]. Bull Soc Pathol Exot 2013;107:15.
5. Bona G, Guidi C. Meningococcal vaccine evolution. J Prev Med Hyg 2012;53:131-5.
6. Meningococcal vaccines: WHO position paper, November 2011. Wkly Epidemiol Rec 2011;86:521-39.
7. Ferrari MJ, Fermon F, Nackers F et al. Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria. Int Health 2014;6:282-90.
8. Sadarangani M, Scheifele DW, Halperin SA et al. The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012. Clin Infect Dis 2014;59:1208-15.
9. Altmann D, Aseffa A, Bash M et al. Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt. Vaccine 2013;31:1453-7.
10. WHO. Meningitis Outbreak Response in Sub-Saharan Africa: WHO Guideline. Geneva: World Health Organization; 2014. http://www.ncbi.nlm.nih.gov/books/NBK274193 [accessed 2 February 2015].